Previous findings obtained in primary GBM cell cultures from various patients [5] as well as in multiple cell lines from different sources (A172, U251) [6,10] confirm that, in GBM an mTOR–dependent pathway is overactive. This evidence concerns the gene MTOR and glioblastoma.